Table 2.
LMO2 Expression in Vascular Neoplasms
| LMO2 | CD31 | CD34 | |
|---|---|---|---|
| Benign | |||
| Angiomatosis | 1/1 | 1/1 | 1/1 |
| Hemangioma | 14/14 | 8/8 | 6/6 |
| Capillary | 5/5 | 4/4 | 3/3 |
| Infantile | 5/5 | 1/1 | 1/1 |
| Epithelioid | 1/1 | 1/1 | 1/1 |
| Histiocytoid | 1/1 | — | — |
| Intramuscular | 1/1 | 1/1 | 1/1 |
| Splenic | 1/1 | 1/1 | — |
| Infantile hemangioendothelioma | 3/3 | — | — |
| Littoral cell angioma | 2/2 | 2/2 | — |
| Lymphangioma | 8/8 | 1/2 | — |
| Malignant | |||
| Angiosarcoma | 25/28 | 17/17 | 8/15 |
| Epithelioid | 4/6 | 6/6 | 1/6 |
| of Pleura | 0/2 | 2/2 | 0/2 |
| Not otherwise specified | 21/22 | 11/11 | 7/9 |
| Hemangioendothelioma | 7/12 | 11/11 | 6/9 |
| Epithelioid | 6/10 | 10/10 | 5/8 |
| of Bone | 1/4 | 4/4 | 3/4 |
| of Pleura | 0/1 | 1/1 | 0/1 |
| of Other sites | 5/5 | 5/5 | 2/3 |
| Spindled | 1/2 | 1/1 | 1/1 |
| Kaposi sarcoma | 7/7 | 4/4 | 4/4 |